AURA

Aura Biosciences Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 3/10
  • Value↑ 5/10
Aura Biosciences sales and earnings growth
AURA Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 8.42%
  • FCF Y/Y↓ -14.47%
Aura Biosciences gross and profit margin trends
AURA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -60.73%
Aura Biosciences net debt vs free cash flow
AURA Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Aura Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks